NSG 552 Psychopharmacology
Exam 1 - Wilkes University
2026/2027 Academic Year | Complete Guide with Verified Answers
Passan School of Nursing | 100% Correct | Grade A
75 Questions | 6 Sections | Neurobiology, Antidepressants, Mood Stabilizers, Anxiolytics
Section 1: Neurobiology and Neurotransmission Fundamentals
(Q1-Q15)
Q1: A psychiatric nurse practitioner is explaining the mechanism of synaptic transmission to a
graduate student. Which sequence correctly describes the process of neurotransmission at a
chemical synapse?
A. Action potential arrives at the presynaptic terminal, calcium enters the terminal,
synaptic vesicles fuse with the presynaptic membrane, neurotransmitter is released into
the synaptic cleft, and binds to postsynaptic receptors [CORRECT]
B. Neurotransmitter is synthesized in the postsynaptic neuron, transported across the
synaptic cleft, and binds to presynaptic autoreceptors to terminate release
C. Neurotransmitter release occurs through passive diffusion across the presynaptic
membrane without requiring calcium or vesicular fusion
D. The postsynaptic neuron releases retrograde messengers that directly open
presynaptic calcium channels to initiate neurotransmitter release
Correct Answer: A
Rationale: Chemical synaptic transmission begins when an action potential arrives at the presynaptic
terminal, causing voltage-gated calcium channels to open. Calcium influx triggers synaptic vesicles
containing stored neurotransmitter to fuse with the presynaptic membrane (exocytosis), releasing
neurotransmitter into the synaptic cleft. The neurotransmitter then diffuses across the cleft and binds to
specific postsynaptic receptors, generating either excitatory or inhibitory postsynaptic potentials. This
process is fundamental to understanding all psychopharmacological agents that modulate synaptic
transmission, including antidepressants, antipsychotics, and anxiolytics.
Q2: Which dopamine pathway is most closely associated with the positive symptoms of
schizophrenia, and which antipsychotic receptor action primarily targets this pathway?
A. Nigrostriatal pathway; D2 receptor blockade causing extrapyramidal symptoms
B. Mesolimbic pathway; D2 receptor antagonism reducing dopaminergic overactivity
[CORRECT]
C. Tuberoinfundibular pathway; D2 receptor blockade causing hyperprolactinemia
D. Mesocortical pathway; D1 receptor agonism improving negative symptoms
Correct Answer: B
Rationale: The mesolimbic dopamine pathway projects from the ventral tegmental area (VTA) to the
nucleus accumbens and other limbic structures. Hyperactivity of this pathway is associated with the
positive symptoms of schizophrenia (hallucinations, delusions, thought disorganization). First-generation
and second-generation antipsychotics exert their primary therapeutic effect through D2 receptor
antagonism in the mesolimbic pathway, reducing dopaminergic overactivity. The nigrostriatal pathway is
associated with motor control and EPS from D2 blockade. The tuberoinfundibular pathway regulates
prolactin release. The mesocortical pathway is associated with negative and cognitive symptoms of
schizophrenia, which are less responsive to D2 antagonism.
Page 1
, NSG 552 Psychopharmacology Exam 1 - Wilkes University 2026/2027
Q3: A patient with schizophrenia is prescribed an antipsychotic that blocks 5-HT2A receptors
in addition to D2 receptors. What is the primary clinical advantage of combined 5-HT2A/D2
receptor antagonism (atypical antipsychotics) compared to D2-only blockade?
A. Faster onset of antipsychotic effect within 24 hours
B. Lower risk of extrapyramidal symptoms and potential improvement of negative
symptoms [CORRECT]
C. Complete elimination of all dopaminergic side effects including hyperprolactinemia
D. Enhanced affinity for D2 receptors allowing lower dosing
Correct Answer: B
Rationale: Second-generation (atypical) antipsychotics combine 5-HT2A receptor antagonism with D2
receptor blockade. The 5-HT2A antagonism in the nigrostriatal pathway promotes dopamine release,
which counteracts the D2 blockade effect and reduces the risk of extrapyramidal symptoms (EPS).
Additionally, 5-HT2A antagonism in the prefrontal cortex may enhance dopamine release in the
mesocortical pathway, potentially improving negative and cognitive symptoms. This combined
pharmacological profile is the defining characteristic of atypical antipsychotics and represents a
fundamental advancement over first-generation agents. However, 5-HT2A/D2 antagonism does not
eliminate hyperprolactinemia risk (except for aripiprazole), and onset of action still requires weeks.
Q4: Which of the following best describes the mechanism of action of benzodiazepines at the
GABA-A receptor?
A. Direct agonist binding to the GABA binding site on the GABA-A receptor
B. Positive allosteric modulation: enhancing GABA-mediated chloride influx by increasing
the frequency of chloride channel opening [CORRECT]
C. Blockade of GABA reuptake at the presynaptic terminal, increasing synaptic GABA
availability
D. Inverse agonism at the benzodiazepine binding site, reducing neuronal excitability
Correct Answer: B
Rationale: Benzodiazepines act as positive allosteric modulators at the GABA-A receptor. They bind to a
specific site on the receptor complex distinct from the GABA binding site, enhancing the effect of
endogenous GABA by increasing the frequency (not duration) of chloride channel opening when GABA is
present. This results in increased chloride influx, neuronal hyperpolarization, and generalized CNS
depression. Benzodiazepines do not directly activate the receptor (they are not direct agonists), do not
block GABA reuptake, and are not inverse agonists. Their effect is dependent on the presence of GABA,
which explains their wide therapeutic index compared to barbiturates. The subunit selectivity of
zolpidem for the alpha-1 subunit contrasts with the broader subunit binding of classical benzodiazepines.
Q5: A graduate nursing student is studying receptor types. Which receptor type produces the
fastest neuronal response (milliseconds) through direct ion channel gating?
A. G-protein coupled receptor (metabotropic)
B. Ligand-gated ion channel (ionotropic) [CORRECT]
C. Intracellular steroid hormone receptor
D. Receptor tyrosine kinase
Correct Answer: B
Rationale: Ligand-gated ion channels (ionotropic receptors) produce the fastest neuronal responses,
occurring within milliseconds. These receptors combine the receptor and ion channel in a single
macromolecular complex, so neurotransmitter binding directly opens the channel, allowing ions to flow
across the membrane. Examples include the GABA-A receptor (chloride channel), NMDA and AMPA
receptors (calcium/sodium channels), and the nicotinic acetylcholine receptor (sodium/potassium
channel). G-protein coupled receptors (metabotropic) produce slower responses (seconds to minutes)
through second messenger cascades. Intracellular receptors (steroid hormones) regulate gene
transcription over hours to days. Receptor tyrosine kinases also produce slower, prolonged effects
through intracellular signaling cascades.
Page 2
, NSG 552 Psychopharmacology Exam 1 - Wilkes University 2026/2027
Q6: Which neurotransmitter system is the primary target of ketamine and esketamine in
treatment-resistant depression, and through which receptor subtype does rapid
antidepressant effect occur?
A. Serotonin system through 5-HT2A receptor antagonism
B. Glutamate system through NMDA receptor antagonism leading to enhanced AMPA
receptor-mediated signaling [CORRECT]
C. Dopamine system through D2 receptor partial agonism
D. Norepinephrine system through alpha-2 adrenergic receptor antagonism
Correct Answer: B
Rationale: Ketamine and its S-enantiomer esketamine produce rapid antidepressant effects (within
hours) primarily through NMDA receptor antagonism. Blockade of NMDA receptors on GABAergic
interneurons disinhibits glutamatergic pyramidal neurons, leading to a surge of glutamate release. This
enhances AMPA receptor-mediated signaling, which activates intracellular pathways (mTOR signaling)
that promote synaptogenesis and synaptic plasticity in the prefrontal cortex. This mechanism is
fundamentally different from monoamine-based antidepressants and represents a paradigm shift in the
treatment of treatment-resistant depression. The rapid onset contrasts with the 2-6 week latency of
conventional antidepressants. Esketamine (Spravato) is FDA-approved for treatment-resistant
depression and depressive symptoms in MDD with acute suicidal ideation.
Q7: A patient with major depressive disorder is prescribed a medication that increases
synaptic serotonin. What is the mechanism by which chronic SSRI administration leads to
enhanced serotonergic transmission, given that acute administration initially increases
synaptic serotonin?
A. Immediate upregulation of postsynaptic 5-HT receptors increases serotonin sensitivity
B. Chronic elevation of synaptic serotonin leads to desensitization (downregulation) of
presynaptic 5-HT1A autoreceptors, allowing greater serotonin release [CORRECT]
C. SSRIs directly stimulate serotonin synthesis enzymes to produce more serotonin
D. SSRIs convert serotonin receptors from inhibitory to excitatory, enhancing signal
transmission
Correct Answer: B
Rationale: The therapeutic mechanism of SSRIs involves a time-dependent adaptation of serotonin
receptors. Acutely, SSRIs increase synaptic serotonin by blocking the serotonin transporter (SERT), but
this initial increase activates presynaptic 5-HT1A autoreceptors, which provide negative feedback and
limit further serotonin release. With chronic administration (2-4 weeks), these 5-HT1A autoreceptors
desensitize (downregulate), reducing the negative feedback constraint on serotonin release. This allows
greater serotonin release and enhanced postsynaptic serotonergic transmission, which correlates with
the delayed onset of therapeutic effect. This receptor adaptation model explains why SSRIs require
weeks to achieve full antidepressant effect despite immediately blocking serotonin reuptake.
Understanding this mechanism is essential for patient education about expected onset of action.
Q8: Which brain region is most directly involved in the pathophysiology of negative symptoms
and cognitive deficits in schizophrenia, and what neurotransmitter abnormality is most
associated?
A. Amygdala; serotonin deficiency
B. Prefrontal cortex; hypodopaminergia in the mesocortical pathway [CORRECT]
C. Hippocampus; excessive glutamate activity
D. Basal ganglia; hyperdopaminergia in the nigrostriatal pathway
Correct Answer: B
Rationale: The prefrontal cortex is the brain region most associated with negative symptoms (avolition,
alogia, anhedonia, asociality, affective flattening) and cognitive deficits in schizophrenia. These
Page 3
Exam 1 - Wilkes University
2026/2027 Academic Year | Complete Guide with Verified Answers
Passan School of Nursing | 100% Correct | Grade A
75 Questions | 6 Sections | Neurobiology, Antidepressants, Mood Stabilizers, Anxiolytics
Section 1: Neurobiology and Neurotransmission Fundamentals
(Q1-Q15)
Q1: A psychiatric nurse practitioner is explaining the mechanism of synaptic transmission to a
graduate student. Which sequence correctly describes the process of neurotransmission at a
chemical synapse?
A. Action potential arrives at the presynaptic terminal, calcium enters the terminal,
synaptic vesicles fuse with the presynaptic membrane, neurotransmitter is released into
the synaptic cleft, and binds to postsynaptic receptors [CORRECT]
B. Neurotransmitter is synthesized in the postsynaptic neuron, transported across the
synaptic cleft, and binds to presynaptic autoreceptors to terminate release
C. Neurotransmitter release occurs through passive diffusion across the presynaptic
membrane without requiring calcium or vesicular fusion
D. The postsynaptic neuron releases retrograde messengers that directly open
presynaptic calcium channels to initiate neurotransmitter release
Correct Answer: A
Rationale: Chemical synaptic transmission begins when an action potential arrives at the presynaptic
terminal, causing voltage-gated calcium channels to open. Calcium influx triggers synaptic vesicles
containing stored neurotransmitter to fuse with the presynaptic membrane (exocytosis), releasing
neurotransmitter into the synaptic cleft. The neurotransmitter then diffuses across the cleft and binds to
specific postsynaptic receptors, generating either excitatory or inhibitory postsynaptic potentials. This
process is fundamental to understanding all psychopharmacological agents that modulate synaptic
transmission, including antidepressants, antipsychotics, and anxiolytics.
Q2: Which dopamine pathway is most closely associated with the positive symptoms of
schizophrenia, and which antipsychotic receptor action primarily targets this pathway?
A. Nigrostriatal pathway; D2 receptor blockade causing extrapyramidal symptoms
B. Mesolimbic pathway; D2 receptor antagonism reducing dopaminergic overactivity
[CORRECT]
C. Tuberoinfundibular pathway; D2 receptor blockade causing hyperprolactinemia
D. Mesocortical pathway; D1 receptor agonism improving negative symptoms
Correct Answer: B
Rationale: The mesolimbic dopamine pathway projects from the ventral tegmental area (VTA) to the
nucleus accumbens and other limbic structures. Hyperactivity of this pathway is associated with the
positive symptoms of schizophrenia (hallucinations, delusions, thought disorganization). First-generation
and second-generation antipsychotics exert their primary therapeutic effect through D2 receptor
antagonism in the mesolimbic pathway, reducing dopaminergic overactivity. The nigrostriatal pathway is
associated with motor control and EPS from D2 blockade. The tuberoinfundibular pathway regulates
prolactin release. The mesocortical pathway is associated with negative and cognitive symptoms of
schizophrenia, which are less responsive to D2 antagonism.
Page 1
, NSG 552 Psychopharmacology Exam 1 - Wilkes University 2026/2027
Q3: A patient with schizophrenia is prescribed an antipsychotic that blocks 5-HT2A receptors
in addition to D2 receptors. What is the primary clinical advantage of combined 5-HT2A/D2
receptor antagonism (atypical antipsychotics) compared to D2-only blockade?
A. Faster onset of antipsychotic effect within 24 hours
B. Lower risk of extrapyramidal symptoms and potential improvement of negative
symptoms [CORRECT]
C. Complete elimination of all dopaminergic side effects including hyperprolactinemia
D. Enhanced affinity for D2 receptors allowing lower dosing
Correct Answer: B
Rationale: Second-generation (atypical) antipsychotics combine 5-HT2A receptor antagonism with D2
receptor blockade. The 5-HT2A antagonism in the nigrostriatal pathway promotes dopamine release,
which counteracts the D2 blockade effect and reduces the risk of extrapyramidal symptoms (EPS).
Additionally, 5-HT2A antagonism in the prefrontal cortex may enhance dopamine release in the
mesocortical pathway, potentially improving negative and cognitive symptoms. This combined
pharmacological profile is the defining characteristic of atypical antipsychotics and represents a
fundamental advancement over first-generation agents. However, 5-HT2A/D2 antagonism does not
eliminate hyperprolactinemia risk (except for aripiprazole), and onset of action still requires weeks.
Q4: Which of the following best describes the mechanism of action of benzodiazepines at the
GABA-A receptor?
A. Direct agonist binding to the GABA binding site on the GABA-A receptor
B. Positive allosteric modulation: enhancing GABA-mediated chloride influx by increasing
the frequency of chloride channel opening [CORRECT]
C. Blockade of GABA reuptake at the presynaptic terminal, increasing synaptic GABA
availability
D. Inverse agonism at the benzodiazepine binding site, reducing neuronal excitability
Correct Answer: B
Rationale: Benzodiazepines act as positive allosteric modulators at the GABA-A receptor. They bind to a
specific site on the receptor complex distinct from the GABA binding site, enhancing the effect of
endogenous GABA by increasing the frequency (not duration) of chloride channel opening when GABA is
present. This results in increased chloride influx, neuronal hyperpolarization, and generalized CNS
depression. Benzodiazepines do not directly activate the receptor (they are not direct agonists), do not
block GABA reuptake, and are not inverse agonists. Their effect is dependent on the presence of GABA,
which explains their wide therapeutic index compared to barbiturates. The subunit selectivity of
zolpidem for the alpha-1 subunit contrasts with the broader subunit binding of classical benzodiazepines.
Q5: A graduate nursing student is studying receptor types. Which receptor type produces the
fastest neuronal response (milliseconds) through direct ion channel gating?
A. G-protein coupled receptor (metabotropic)
B. Ligand-gated ion channel (ionotropic) [CORRECT]
C. Intracellular steroid hormone receptor
D. Receptor tyrosine kinase
Correct Answer: B
Rationale: Ligand-gated ion channels (ionotropic receptors) produce the fastest neuronal responses,
occurring within milliseconds. These receptors combine the receptor and ion channel in a single
macromolecular complex, so neurotransmitter binding directly opens the channel, allowing ions to flow
across the membrane. Examples include the GABA-A receptor (chloride channel), NMDA and AMPA
receptors (calcium/sodium channels), and the nicotinic acetylcholine receptor (sodium/potassium
channel). G-protein coupled receptors (metabotropic) produce slower responses (seconds to minutes)
through second messenger cascades. Intracellular receptors (steroid hormones) regulate gene
transcription over hours to days. Receptor tyrosine kinases also produce slower, prolonged effects
through intracellular signaling cascades.
Page 2
, NSG 552 Psychopharmacology Exam 1 - Wilkes University 2026/2027
Q6: Which neurotransmitter system is the primary target of ketamine and esketamine in
treatment-resistant depression, and through which receptor subtype does rapid
antidepressant effect occur?
A. Serotonin system through 5-HT2A receptor antagonism
B. Glutamate system through NMDA receptor antagonism leading to enhanced AMPA
receptor-mediated signaling [CORRECT]
C. Dopamine system through D2 receptor partial agonism
D. Norepinephrine system through alpha-2 adrenergic receptor antagonism
Correct Answer: B
Rationale: Ketamine and its S-enantiomer esketamine produce rapid antidepressant effects (within
hours) primarily through NMDA receptor antagonism. Blockade of NMDA receptors on GABAergic
interneurons disinhibits glutamatergic pyramidal neurons, leading to a surge of glutamate release. This
enhances AMPA receptor-mediated signaling, which activates intracellular pathways (mTOR signaling)
that promote synaptogenesis and synaptic plasticity in the prefrontal cortex. This mechanism is
fundamentally different from monoamine-based antidepressants and represents a paradigm shift in the
treatment of treatment-resistant depression. The rapid onset contrasts with the 2-6 week latency of
conventional antidepressants. Esketamine (Spravato) is FDA-approved for treatment-resistant
depression and depressive symptoms in MDD with acute suicidal ideation.
Q7: A patient with major depressive disorder is prescribed a medication that increases
synaptic serotonin. What is the mechanism by which chronic SSRI administration leads to
enhanced serotonergic transmission, given that acute administration initially increases
synaptic serotonin?
A. Immediate upregulation of postsynaptic 5-HT receptors increases serotonin sensitivity
B. Chronic elevation of synaptic serotonin leads to desensitization (downregulation) of
presynaptic 5-HT1A autoreceptors, allowing greater serotonin release [CORRECT]
C. SSRIs directly stimulate serotonin synthesis enzymes to produce more serotonin
D. SSRIs convert serotonin receptors from inhibitory to excitatory, enhancing signal
transmission
Correct Answer: B
Rationale: The therapeutic mechanism of SSRIs involves a time-dependent adaptation of serotonin
receptors. Acutely, SSRIs increase synaptic serotonin by blocking the serotonin transporter (SERT), but
this initial increase activates presynaptic 5-HT1A autoreceptors, which provide negative feedback and
limit further serotonin release. With chronic administration (2-4 weeks), these 5-HT1A autoreceptors
desensitize (downregulate), reducing the negative feedback constraint on serotonin release. This allows
greater serotonin release and enhanced postsynaptic serotonergic transmission, which correlates with
the delayed onset of therapeutic effect. This receptor adaptation model explains why SSRIs require
weeks to achieve full antidepressant effect despite immediately blocking serotonin reuptake.
Understanding this mechanism is essential for patient education about expected onset of action.
Q8: Which brain region is most directly involved in the pathophysiology of negative symptoms
and cognitive deficits in schizophrenia, and what neurotransmitter abnormality is most
associated?
A. Amygdala; serotonin deficiency
B. Prefrontal cortex; hypodopaminergia in the mesocortical pathway [CORRECT]
C. Hippocampus; excessive glutamate activity
D. Basal ganglia; hyperdopaminergia in the nigrostriatal pathway
Correct Answer: B
Rationale: The prefrontal cortex is the brain region most associated with negative symptoms (avolition,
alogia, anhedonia, asociality, affective flattening) and cognitive deficits in schizophrenia. These
Page 3
